If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Johnson & Johnson's Bumpy Road: One company that has been a solid investment in the past two years has been pharmaceutical giant Johnson & Johnson (NYSE:JNJ).